Arquer Diagnostics’ ADXBLADDER Undergoes U.S. Clinical Trials
ADXBLADDER, a urinary biomarker test for bladder cancer, is currently undergoing clinical trials in the U.S.
Read MorePosted by Chris Wolski | Jul 28, 2021 | Unknown Origin & Other Cancer Types, Urinalysis & Toxicology |
ADXBLADDER, a urinary biomarker test for bladder cancer, is currently undergoing clinical trials in the U.S.
Read MorePosted by Chris Wolski | Jul 28, 2021 | Covid 19, Information Technology, Rapid Assays |
iXensor Co., Ltd. has launched a new version of its integrated COVID-19 screening solution, the PixoHealth Pass Admin App and Web Portal.
Read MorePosted by Melanie Hamilton-Basich | Jul 27, 2021 | Molecular Diagnostics |
Phosphorus’ GeneCompass test kit uses the latest NGS technology to analyze genes associated with more than 200 health risks and over 200 genetic drug interactions.
Read MorePosted by Melanie Hamilton-Basich | Jul 26, 2021 | Covid 19 |
As part of President Biden’s national testing initiatives, more testing in congregate settings aims to help prevent infections as the Delta variant spreads and vaccinations continue to increase.
Read MorePosted by Melanie Hamilton-Basich | Jul 26, 2021 | Covid 19 |
The FDA cites de-prioritization due to high volume of EUA reviews and recommends a different approval pathway for the SQI COVID-19 RALI-Dx IL-6 Severity Triage Test.
Read More